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Abstract 
Primary liver cancer is the fifth most common malig-
nancy in men and the eighth in women worldwide. 
The liver is also the second most common site for 
metastatic spread of cancer. To assist in the diagnosis 
of these liver lesions non-invasive advanced imaging 
techniques are desirable. Magnetic resonance (MR) is 
commonly used to identify anatomical lesions, but it is 
a very versatile technique and also can provide specific 
information on tumor pathophysiology and metabo-
lism, in particular with the application of MR spectros-
copy (MRS). This may include data on the type, grade 
and stage of tumors, and thus assist in further man-
agement of the disease. The purpose of this review is 
to summarize and discuss the available literature on 
proton, phosphorus and carbon-13-MRS as performed 
on primary liver tumors and metastases, with human 
applications as the main perspective. Upcoming MRS 
approaches with potential applications to liver tumors 
are also included. Since knowledge of some technical 
background is indispensable to understand the results, 
a basic introduction of MRS and some technical issues 
of MRS as applied to tumors and metastases in the 
liver are described as well. In vivo  MR spectroscopy of 
tumors in a metabolically active organ such as the liver 
has been demonstrated to provide important informa-
tion on tumor metabolism, but it also is challenging 
as compared to applications on some other tissues, in 
particular in humans, mostly because of its abdominal 
location where movement may be a disturbing factor. 
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INTRODUCTION
Primary liver cancer is the fifth most common malignan-
cy in men and the eighth in women worldwide. In 2000, 
it was estimated that there were about 564 000 new cases 
of  liver cancer worldwide, and a similar number of  pa-
tients died as a result of  this disease[1]. Also, the liver is 
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the second most common site for metastatic spread of  
cancer[2]. In fact, liver lesions are more likely to represent 
a metastatic tumor than a primary liver tumor[3,4]. For 
further clinical management a proper diagnosis is crucial. 
Currently tissue sample analysis by histopathology is the 
golden standard for the diagnosis of  suspected cancer in 
the liver. However, taking biopsies for histopathological 
analysis has some disadvantages. Besides patient discom-
fort, there is a change that the needle misses the cancer 
foci. Also, the needle might loosen cancerous cells which 
could result in tumor dissemination outside the liver 
along the needle track[5].
Thus, non-invasive advanced imaging techniques are 
desirable to assist in the diagnosis of  liver lesions. A major 
modality to obtain anatomical information is magnetic 
resonance (MR). The MR technique is very versatile and it 
also offers many possibilities to acquire more functional in-
formation. Among these, MR spectroscopy (MRS) is par-
ticular interesting as it can provide specific information on 
tumor pathophysiology and metabolism. This may include 
data on the type, grade and stage of  the tumor, which thus 
can assist in further management of  the disease.
In this review, we will summarize and discuss the 
available literature on MRS of  primary liver tumors and 
metastases. We will focus on the main nuclei employed 
in MRS, proton (1H), phosphorus-31 (31P) and carbon-13 
(13C). Since knowledge of  some technical background 
is indispensable to appreciate the impact of  the results 
described in this paper we first give an introduction into 
the basics of  MRS and some technical issues of  MRS as 
applied to tumors and metastases in the liver.      
BASIC CONCEPTS OF MAGNETIC 
RESONANCE SPECTROSCOPY
In vivo MRS allows for the noninvasive measurement of  
the levels of  some compounds in body tissues. It exploits 
the magnetic properties of  certain atomic nuclei that are 
present in these molecules. The nuclei that are best acces-
sible for in vivo MRS experiments are those of  proton (1H), 
phosphorus (31P) and carbon-13 (13C) atoms. 
The following sections present a short introduction 
of  MR spectroscopy to provide the reader with suffi-
cient background to understand the biological and clini-
cal applications of  MR spectroscopy. For more in-depth 
information the reader is referred to other publications, 
see for example[6].
MR spectra
The key feature of  MR spectroscopy is that certain bio-
chemical compounds, mostly metabolites, can be identi-
fied in an MR spectrum by their specific spectral pattern, 
which is composed of  one or more distinct signals. 
The intensity of  the signal is proportional to the tissue 
amount of  a certain nuclei and thus reflects the tissue 
levels of  the compound in which it is present. An exam-
ple of  a typical in vivo 1H MR spectrum of  a healthy liver 
is shown in Figure 1. The horizontal axis of  a spectrum 
represents the resonance frequency or chemical shift 
(both terms are explained below), the vertical axis repre-
sents the signal intensity. This spectrum is dominated by 
three main signals and in addition there are some smaller 
peaks, and broad underlying resonances. In the next few 
sections we explain in more detail how this spectrum is 
obtained and what particular information can be extract-
ed from it.
Larmor frequency
Atomic nuclei with unpaired neutrons and/or protons, 
are detectable by nuclear magnetic resonance (NMR). 
As the nucleus is spinning around its axes and bears an 
electric charge it is associated with a magnetic dipole that 
can be seen as a tiny bar magnet (Figure 2). Outside a 
magnetic field these nuclear spins or tiny magnets have 
a random orientation; however, when placed in a strong 
constant external magnetic field B0 they will become 
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Figure 1  In vivo 1H magnetic resonance spectra of human liver tissue 
obtained from a healthy volunteer on a 3.0T magnetic resonance system. 
Above: Spectrum with unsuppressed water signal; Below: Spectrum with partial 
suppressed water signal, showing the overlapping resonances for N-(CH3)3 pro-
tons at about 3.2 ppm occurring in choline compounds (tCho) and resonances 
for specific protons in lipids.
aligned (Figure 3). The nuclear spins of  the atoms 1H, 
31P and 13C can be oriented parallel or anti-parallel to 
B0. However, the spins do not exactly align but are at an 
angle to B0. This causes them to precess around the axis 
of  B0 with the so-called Larmor frequency ν0 = ω0/2π = 
γB0/2π where the gyromagnetic ratio γ has a specific value 
for each nucleus (Figure 4). This implies that every type 
of  nucleus has a different precession frequency, propor-
tional to the B0 field strength. At a field strength of  3T, 
which is commonly used for human applications, these 
frequencies for 1H, 31P and 13C are: 127.7 MHz, 51.8 MHz 
and 32.1 MHz respectively, which is in the radiofrequency 
range.
Energy levels
The parallel and anti-parallel orientations are associated 
with a low and a high energy state respectively. The en-
ergy difference between the two spin states equals 
          E = h γ B0    [Equation 1], 
where h is Planck’s constant (h = 6.626 × 10-34 J/s). 
At room temperature, there are slightly more spins in 
the lower energy level, Nα, than in the upper level, Nβ. 
The distribution over these energy levels is given by 
Boltzmann statistics 
          Nβ/Nα = e-E/kT                [Equation 2], 
where k is Boltzmann’s constant (1.3805 × 10-23 J/K) 
and T is the temperature in Kelvin. The population dif-
ference results in a net macroscopic magnetization M0. 
This so-called longitudinal magnetization is aligned par-
allel to B0 (Figure 5). Only the net magnetization is de-
tectable and its extent determines the achievable signal-
to-noise ratio (SNR). At 1.5T and 37 ℃ (310 K), the 
population difference represents only a small fraction 
(about 10-6) of  the total spin population, which explains 
why MR is a relatively insensitive technique. It follows 
from Equations 1 and 2 that sensitivity can be improved 
with a higher magnetic field B0 or a lower temperature.
Flip angle, free-induction decay, T1 and T2
The direction of  the main magnetic field B0, is com-
monly placed along the z-axis and the magnetization 
along this axis is Mz, which at equilibrium, equals M0 
(Figure 5). The longitudinal magnetization however is 
not detectable as it is “overruled” by the main magnetic 
field B0. To detect the net macroscopic magnetization 
M0, an radio frequency (RF) pulse with a magnetic field 
perpendicular to the main magnetic field B0 and with a 
frequency equal to the precession frequency is sent with 
an RF transmitter coil. As a consequence of  the applied 
RF pulse M0 magnetization will rotate away from the 
z-axis toward the transverse plane (x-y plane). The angle 
to which the net magnetization is rotated relative to the 
main magnetic field direction is called the flip angle. A 
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Figure 5  The direction of the main magnetic field B0, is commonly placed 
along the z-axis and the magnetization along this axis is Mz, which at equi-
librium, equals M0. Left: Multiple individual spins precessing with the Larmor fre-
quency around the axis of B0. The spin vectors have a random, incoherent phase 
with respect to each other. Right: Magnetization vector Mz, which at equilibrium, 
equals M0 (right).
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so called 90° RF excitation pulse will therefore rotate 
M0 into the transverse plane. The spin population of  the 
energy levels becomes equal and spins precess coher-
ently (Figure 6). However, after the RF excitation pulse 
the spins start to return towards the original energy level 
distribution and towards incoherent precession (dephas-
ing) and after a while the system will be in equilibrium 
again. The time constant which describes how the mag-
netization returns to the original longitudinal alignment is 
called the spin lattice relaxation time T1: Mz = M0 (1-e-t/T1). 
The time constant which describes the return to incoher-
ent precession is called the spin-spin relaxation time T2: 
Mxy = Mxy0 e-t/T2. By definition T1 is longer than T2.
After the RF pulse, the transverse component of  the 
M0 magnetization precesses with the Larmor frequency 
at resonance and will induce a current in the RF coil 
which is now switched to receive mode. The decaying 
signal of  this component is called the free-induction 
decay (FID) response signal. This digitally recorded FID 
signal is mathematically converted by a Fourier trans-
form from the time to the frequency domain, which 
results in a so called MR spectrum, that may contain one 
or more resonances, signals or peaks at particular fre-
quencies. 
Shielding and chemical shift
An MR spectrum of  the liver would not be very inter-
esting if  all nuclei of  a certain type resonate at the same 
frequency. Fortunately, each nucleus in a given molecule 
is shielded from the main field by a weak opposing field 
from the surrounding electrons, induced by and also 
proportional to B0. The amount of  shielding by these 
electrons highly depends on the chemical environment 
of  the nucleus. This shielding, which is generally unique 
for each chemically distinguishable site in a molecule, is 
expressed as the shielding constant σ, and the total effec-
tive field experienced by a given nucleus is: Beff  = B0 (1-σ). 
The resulting change in resonance frequency νeff  = ωeff/2π 
= γ B0 (1-σ)/2π relative to that of  a chosen reference 
compound, νref, is generally referred to as the chemical 
shift σ = (νeff - νref )/νref expressed in units of  ppm (1 ppm 
= 100 Hz at ν0 = 100 MHz). Thus the chemical shift is 
the key property of  MR spectroscopy which enables 
detection of  a wide variety of  chemical groups and me-
tabolites containing these groups. Special RF pulses are 
used to excite a band of  frequencies covering the chemi-
cal shift range of  a particular nucleus in a biological 
sample. 
1H MR SPECTRUM OF THE LIVER 
EXPLAINED
As shown in Figure 1 the 1H spectrum of  the liver is 
dominated by 3 peaks. The peak on the right originates 
from the 1H nuclei in methylene groups (-CH2-) in lipids, 
the peak in the middle originates from the 1H nuclei in 
the three methyl groups (CH3) of  choline containing 
compounds [(CH3)3N+CH2CH2O-], and the peak on the 
left originates from the 1H nuclei in water (H2O). The 
electronegative oxygen atom in the water molecule shifts 
the electron density away from the 1H nuclei, leading to 
a reduced shielding and thus to a higher resonance fre-
quency compared to 1H nuclei in the methylene groups 
of  lipids. Thus 1H nuclei in water have a higher chemical 
shift value then the 1H nuclei in the methylene groups 
from lipids (compared to 1H nuclei in a reference com-
pound at 0 ppm) and appear on the left side. Note that 
the chemical shift scale on the horizontal axis increases 
from right to left. 
The peak area rather than its amplitude is propor-
tional to the amount of  1H nuclei in the same chemical 
environment and thus the tissue content of  that chemi-
cal group or metabolite. Quantification of  metabolite 
concentrations is performed by comparing peak areas 
with those of  known substances and concentrations.
The content of  water in the liver is much higher than 
that of  metabolites. Hence, the proton signals of  the lat-
ter have a much lower SNR (Figure 1). For this reason 
signal averaging is usually required and it is also needed 
to measure larger voxels than commonly done with MR 
imaging of  water. 
WATER SIGNAL SUPPRESSION
As the water resonance in 1H MR spectra is at least 200 
times more intense than the resonances of  hydrogen 
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the energy levels become equal and the spins precess coherently (middle). The magnetization vector M0, rotates into the transverse (x-y) plane (right).
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containing metabolites (Figure 1) it may hamper the 
proper detection of  metabolite signals, e.g., by artifacts 
such as side bands of  this huge signal[7], the suppression 
of  the water signal is commonly performed. There are 
many ways to do this: a well-known sequence is chemical 
shift selective water suppression[8]. A frequency selective 
RF pulse excites the water spin magnetization into the 
transverse plane after which all coherences are dephased 
by magnetic field gradients. The spectrum shown in 
Figure 1 was obtained with only partial water signal sup-
pression.
MAGNETIC FIELD HOMOGENEITY 
As the purpose of  MR spectroscopy is to separate signals 
with different chemical shift it is crucial for its proper 
application that good magnetic field homogeneity is ob-
tained over the object of  interest. However, due to the 
many different tissue types and air containing compart-
ments, the magnetic field in the human body is usually 
not very homogeneous, leading to broadened spectral 
lines, which may overlap. Therefore optimizing field 
homogeneity (a process called shimming) is usually a 
required step in an MR spectroscopy experiment. Good 
homogeneity is most important in 1H MRS as it has a 
relatively small chemical shift range and needs a well sep-
arated and defined water signal for proper suppression 
and to avoid artifacts. By selecting small volumes of  in-
terest, a limited amount of  different tissues are included 
which will result in a more homogeneous magnetic field. 
The requirements for homogeneity are much less strict 
for 31P and 13C MRS because resonances in their spectra 
are more separated (larger spectral dispersion). 
SPIN-SPIN COUPLING AND DECOUPLING
Nuclei which are close to one another exert an influence 
on each other’s effective magnetic field through elec-
trons in chemical bonds (Figure 7). If  the distance be-
tween non-equivalent nuclei is less than or equal to three 
bond lengths, this effect may be observable in the in vivo 
MR spectrum. Instead of  one peak for a certain nucleus 
several smaller peaks are observed in the spectrum. This 
interaction of  nuclei is often referred to as scalar cou-
pling, J coupling or spin-spin coupling. Because of  this 
splitting the signal to noise decreases and spectral inter-
pretation may become more complicated. However, the 
specific pattern may also be helpful to identify specific 
molecular groups and with special pulse sequences the 
phenomenon of  spin-spin coupling may be used to 
identify the resonances of  these groups in the presence 
of  other overlapping resonances (so-called editing).  
Spin-spin couplings are expressed in Hz. A typical 
value for a three bond proton-proton coupling in metabo-
lites is 7 Hz. For example this can be used to identify the 
methyl doublet resonance of  lactate in 1H MR spectra. 
At magnetic fields above about 2T, line width broaden-
ing will obscure the direct visualization of  this coupling. 
Two bond 31P - 31P couplings occur at about 17 Hz in 
adenosine triphosphate (ATP). Heteronuclear couplings 
commonly dealt with in in vivo MRS are between protons 
and 31P or 13C. To improve signal to noise and spectral 
resolution the spin-spin splitting can be removed by a 
technique called decoupling. Special RF pulses are used 
to irradiate selected resonance(s) of  nuclear spins such 
that their field directionality is averaged out. As a result 
nearby spins in a molecule experience no field of  these 
irradiated spins anymore and the resonance splitting dis-
appears. 
Decoupling is important in MRS of  31P and 13C as 
these atoms often show split resonances due to nearby 
hydrogen atoms. Irradiation of  these protons for de-
coupling increases the signal to noise ratio and impro-
ves spectral resolution. Irradiation also induces a throu-
gh space effect called nuclear overhauser enhance-
ment (NOE), which can increase signal intensity even 
more[9-11]. Typical enhancement values reached in vivo by 
NOE are 1.3-2.9 and 1.4-1.8 for 13C-1H and 31P-1H inter-
actions respectively[6].
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DYNAMIC NUCLEAR POLARIZATION
13C labeled (enriched) substrates combined with 13C MRS 
have traditionally been used to monitor metabolic con-
versions during steady-state conditions and even has been 
used to assess active metabolism in human tumors[12-14]. 
The relative low sensitivity of  13C MRS prevented imag-
ing of  these processes. However, with polarization trans-
fer techniques sensitivity can be enhanced[14-16].
Recently a new method has been introduced in bio-
medical MR, dynamic nuclear polarization (DNP), 
that mostly makes use of  13C MRS, to image metabolic 
conversions at reduced acquisition times (in an order 
of  minutes or less). Inspection of  Equation 2 (above) 
reveals that decreasing the temperature also will increase 
the population differences between energy levels. DNP is 
a hyperpolarization technique that increases the spin po-
larization obtained at room or body temperature in tradi-
tional MR, by orders of  magnitude by cooling the sample 
to very low temperatures and using selective microwave 
irradiation for efficient transfer of  spin polarization from 
electron spin to nuclear spin[6,17,18]. The substrate is then 
rapidly transferred to body temperature for administra-
tion. The major disadvantage of  DNP is that the polar-
ization decay is determined by the spin-lattice relaxation 
time T1 of  the nucleus (20-40 s for a 13C nucleus in a car-
boxyl group). The consequence is that only conversions 
in which substrates are rapidly taken up by tissues and 
metabolized within minutes can be imaged successful. 
With efficient uptake usually one or two metabolic steps 
can be imaged, before the signal has decayed away. 
LOCALISATION
To analyze different regions of  interest in the liver with 
healthy tissue or tumor lesions by in vivo MRS it is re-
quired that only signals that originate from these loca-
tions appear in the spectra. This can be achieved in 
different ways. The most rudimentary one is to use only 
a surface coil on the body adjacent to the liver with a 
simple pulse sequence globally selecting the area next to 
the coil. However, in most cases a better localization is 
desired. More advanced spatial localization is possible 
with single voxel or multi-voxel methods.  
Single voxel localization
The most common single voxel localization techniques 
are Image Selected In Vivo Spectroscopy (ISIS)[19], Stimu-
lated Echo Acquisition Mode (STEAM)[20] and Point 
Resolved Spectroscopy (PRESS)[21].
ISIS uses three frequency-selective inversion pulses, 
in the presence of  three orthogonal magnetic field 
gradients. By turning on and off  the inversion pulses, 
according to an encoding scheme, eight different scans 
are recorded. Adding and subtracting the different scans 
will add signal from the desired location while canceling 
signal from other locations. A disadvantage of  ISIS is its 
sensitivity to motion as eight scans need to be obtained 
for a full 3D localization. ISIS is rarely used for 1H MRS, 
because of  potential artifacts such as those arising from 
incomplete water signal suppression. However, it is the 
favored method in 31P MRS localization as effects due to 
relatively rapid T2 decay and to J-coupling are avoided.  
For 1H MRS the most common single voxel localiza-
tion techniques are STEAM and PRESS, which both 
use three spatially slice selective RF pulses to produce 
an echo signal from a well-defined region. STEAM uses 
90°-90°-90° pulses and PRESS 90°-180°-180° pulses 
to define three orthogonal slices. Only signal from the 
volume of  interest remains in the final echo. In STEAM 
50% of  the original signal is lost as the second 90° pulse 
only rotates half  of  the transverse magnetization to the 
longitudinal axis, while the other half  is dephased by 
crushers. The PRESS technique retains full signal inten-
sity, but the minimal possible TE is commonly larger 
than for STEAM. 
Multi voxel localization
Multi voxel localization allows the detection of  localized 
spectra from a multidimensional array of  locations. Dis-
advantages compared to single voxel localization con-
cerns some more magnetic field inhomogeneities due to 
the many different tissue types in the field of  view, inter-
voxel contamination, and the minimally required number 
of  scans that may end up in long acquisition times. Spec-
troscopic imaging techniques acquire the signal from 
multiple voxels by using phase encoding gradients[22], 
analogous to the phase encoding technique used in MR 
imaging. The nominal voxel size is the field of  view di-
vided by the number of  phase encoding gradient steps. 
The actual voxel size can deviate substantially from the 
nominal value as the signal is sampled only over a finite 
time. This introduces intervoxel contamination due to 
the characteristics of  the Fourier transform. This voxel 
bleeding can be decreased by apodization functions like 
those with Gaussian or Hamming shapes, however at the 
expense of  decreased spatial resolution. 
Conventional encoding of  N1 × N2 × N3 volume 
elements (voxels) requires N1 × N2 × N3 acquisitions. A 
typical 16 × 16 × 16 dataset obtained with a repetition 
time of  2000 ms and 4 averages would require a mea-
suring time of  (16 × 16 × 16 × 2000 × 4/3600 = 9 h). 
Therefore techniques are developed that increase the 
temporal resolution, e.g., by special k-space trajectories. 
For example “circular 2D or spherical 3D k-space sam-
pling with k-space apodization during acquisition”. This 
also reduces the total acquisition time by spending less 
time acquiring the high k-space coordinates and more 
time acquiring the low k-space coordinates. Other meth-
ods are based on fast magnetic resonance imaging (MRI) 
sequences, e.g., EPI, RARE, spiral and steady-state se-
quences[6].
QUANTIFICATION
Although the tissue level of  metabolites is proportional 
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to the area under its signal curve in the spectrum, it 
commonly requires some corrections and calibration 
with a signal of  known concentration to obtain an abso-
lute number (e.g., in mmol/L). 
Such a reference signal maybe that of  water or of  
another metabolite in the liver assuming a stable and 
known value for its tissue level. In the liver, the unsup-
pressed water signal is often used as an internal refer-
ence after correction for T1 and T2 relaxation. However, 
dietary regimes and liver pathologies may affect the 
amount of  water. Li et al[23] reported a 1.8 fold differ-
ence in five normal liver studies between the largest and 
smallest water signal intensity obtained from localized 
liver tissues. In four hepatocellular carcinoma studies, 
they observed a 3.2-fold difference between the largest 
and smallest water signal intensities obtained from the 
localized liver tumors. Lipid peaks exhibited even larger 
variations than did the water peaks.
External phantoms with known concentrations 
sometimes are also used for calibration purposes, but 
this may be not so practical in a clinical environment. 
In addition differences in coil loading have to be taken 
into account in this approach. To avoid correction and 
calibration issues spectral quantities are sometimes also 
assessed as ratio’s between integrals of  signals of  differ-
ent compounds.
MOTION AND OTHER ARTEFACTS
Motion can lead to voxel misregistration and outervoxel 
contamination. Motion of  tissue through inhomoge-
neous fields (e.g., air in the lungs) results in broadening 
of  the spectral resonances. Broadening of  the reso-
nances increases the risk of  signal overlap and also low-
ers the signal to noise ratio. Compared to other organs 
like brain and skeletal muscle, MR spectroscopy of  the 
liver is challenging as there are potential field inhomo-
geneities and artifacts caused by respiratory movement, 
cardiac and aortic pulsations[24-26]. Although often ap-
plied, breath-hold acquisitions may be problematic. Long 
acquisition times are needed to increase the SNR and, 
since a breath-hold period can only last for about 15 s 
in patients, the acquisition will require multiple breath-
hold periods. Even when the acquisition is performed at 
end-expiration, there is no guarantee that the tissue is at 
exactly the same position, leading to outervoxel contami-
nation. Respiratory and cardiac gating can be applied 
to reduce motion artifacts at the cost of  an increased 
scan time. Another option is to align individual spectra 
and/or exclude bad spectra before averaging during post 
processing. Some liver pathologies, e.g., due to long-term 
total parenteral nutrition may induce iron accumulation 
in the liver, which will result in field inhomogeneities and 
broadening of  the spectral resonances.
REPRODUCIBILITY
In order to predict treatment outcome or monitor thera-
py, differences in in vivo MR spectroscopy outcome para-
meters should reflect true differences in tumor biology 
and not differences induced by variations in the MRS 
protocol or interfering body physiology. This issue is 
relevant, since the time of  MR scanning during the day 
(e.g., before or after a meal) or differences in eating pat-
terns might already influence the metabolic activity and 
thus the concentrations of  metabolites in the liver. Large 
inter- and intrapatient variability of  MRS outcome pa-
rameters have been described[23].
1H MR SPECTROSCOPY
In MR, hydrogen (proton) is the most commonly studied 
nucleus. Compared to other MR sensitive nuclei it has 
the highest sensitivity and occurs at 100% isotopic abun-
dance. Almost all metabolites in the human body contain 
protons. Therefore, in principle a large amount of  metab-
olites can be investigated. However, in practice, sensitivity 
restrictions set the in vivo detection limit of  metabolites to 
a minimum tissue concentration of  about 0.1 mmol/L. 
An advantage of  1H MRS is that it uses the same nucleus 
as MRI techniques. Therefore, it can be performed with 
the same hardware and there is no need for special equip-
ment. The major drawback of  1H MRS is the relatively 
small chemical shift range (about 10 ppm) for the many 
resonances of  in vivo detectable compounds, resulting in 
limited spectral resolution. Moreover, these have to be 
resolved from a dominating water peak, in certain cases 
a large lipid peak, and at short echo times a high baseline 
due to macro-molecules.
Metabolites visible in 1H MR spectra of liver tumors 
Lipids: Outside the brain 1H MR spectra of  tissues usu-
ally show large signals of  mobile lipids, mostly triglyc-
erides: in particular a methylene peak at 1.2 ppm with 
smaller methylene peaks between 2.1 and 2.4 ppm and a 
peak for methyl protons at 0.9 ppm (Figure 1). Triglyc-
erides occur in fatty liver, but also may be a marker of  
membrane breakdown and can be seen in tumors, ab-
scesses and other pathological processes[27].
Lactate: Due to the Warburg effect tumor cells obtain 
relative less energy than normal cells from oxidative 
phosphorylation and have a more glycolytic character[28,29]. 
Pyruvate, the end product of  glycolysis, is converted into 
lactate, which is further promoted by hypoxic conditions. 
Therefore MR spectra of  tumor tissue often show signals 
for lactate. The three equivalent methyl protons of  lactate 
give rise to a resonance at 1.31 ppm, which is a doublet 
due to coupling with the methylene proton, while the sin-
gle methylene proton resonates as a quartet at 4.10 ppm 
due to coupling with the methyl protons. In liver and tu-
mor tissue, the lactate signal at 1.3 ppm will overlap with 
large lipid resonances. However, with so-called spectral 
editing techniques it is possible to separate the lactate sig-
nal from the lipid signals.
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Creatine: Creatine (Cr) and phosphorylated creatine 
(PCr) play an important role in energy metabolism of  
many tissues. PCr serves as a spatio-temporal energy 
buffer, maintaining a constant level of  ATP, facilitated 
by the creatine kinase reaction. The methyl protons of  
Cr and PCr resonate at about 3.03 ppm and the methy-
lene protons resonate at approximately 3.9 ppm. Under 
normal conditions, the concentration of  total creatine is 
relatively constant in muscle and brain and therefore of-
ten used as an internal reference. However, decreased Cr 
levels have been observed in tumors and other patholo-
gies. Furthermore, hepatocytes do not express creatine 
kinase under normal circumstances[30], and therefore no 
creatine peak will be visible in the spectrum of  healthy 
liver tissue. In vitro experiments at 9.4T have shown 5-10 
times increased levels of  Cr in liver metastasis compared 
to normal liver tissue[31].
Choline and ethanolamine containing compounds
The signals of  choline containing compounds in MR 
spectra have been used as key biomarkers to identify 
malignant tumors[32-34]. In vivo 1H MR spectra of  the liver 
show the N-trimethyl [+N(CH3)3] resonances of  choline 
compounds at about 3.2 ppm. This resonance is also 
known as the total choline (tCho) peak as it may origi-
nate from several different choline compounds. The rel-
ative increase in the tCho signal seen in human tumors is 
due to an abnormal choline uptake and/or metabolism 
related to cell membrane turnover. However, metabolism 
of  choline containing compounds in tissue cells is com-
plex. Although far less prominent in 1H MR spectra than 
choline, ethanolamine signals may also contribute to a 
characteristic spectral profile of  tumor tissue. Therefore 
some important biochemical pathways involving choline 
metabolism and the closely related metabolism of  etha-
nolamine in the liver are briefly described (Figure 8).
Choline and ethanolamine metabolism
Choline is a key precursor molecule in several metabolic 
pathways. It can be acetylated, oxidized, phosphorylated 
or hydrolyzed. Choline oxidation plays a major role in 
the provision of  methyl groups via its metabolite, tri-
methylglycine (betaine) that participates in the synthesis 
of  S-adenosylmethionine (SAM). Methylation reactions 
are involved in the biosynthesis of  lipids, the regulation 
of  several metabolic pathways, and detoxification in the 
body. Choline phosphorylation results in compounds 
such as phosphatidylcholine (PtdCho), lysophosphatidyl-
choline, choline plasmalogen, and sphingomyelin which 
are essential for structural integrity and signaling in cell 
membranes[35-38]. 
PtdCho, the major phospholipid component of  
cells is derived from the Kennedy pathway[39], which 
has two branches, one via cytidine 5’diphospho (CDP)-
choline and the other via CDP-ethanolamine (Figure 8). 
In the CDP-choline branch choline is initially converted 
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Figure 8  Simplified schematic overview of choline and ethanolamine metabolism including parts of the Kennedy pathway, the methionine and folate cycle. 
B12: Vitamin B12; BHMT: Betaine-homocysteine methyltransferase; CDP-Cho: Cytidine diphosphate-choline; CDP-Etn: Cytidine diphosphate-ethanolamine; DMG: 
Dimethylglycine; Etn: Ethanolamine; GPCho: Glycerol-3-phosphorylcholine; GPEtn: Glycerol-3-phosphorylethanolamine; MS: Methionine synthase; PCho: Phosphor-
ylcholine; PEtn: Phosphorylethanolamine; PtdCho: Phosphatidylcholine; PtdEtn: Phosphatidylethanolamine; THF: Tetrahydrofolate; 5mTHF: 5-methyltetrahydrofolate; 
TMG: Trimethylglycine (betaine).
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to phosphorylcholine (PCho) and after some steps to 
PtdCho which can be converted into choline or into 
PCho again[36]. Alternatively, phosphatidylethanolamine 
(PtdEtn) is generated via the CDP-ethanolamine branch, 
employing similar biochemical reaction steps. The result-
ing PtdEtn can be methylated, using SAM as the methyl 
donor, to PtdCho[36-38,40]. The methylation pathway is, 
however, only relevant in liver. In rat hepatocytes it ac-
counts for 20%-40% of  PtdCho synthesis[41]. Besides en-
tering the CDP-choline branch of  the Kennedy pathway, 
choline can also enter another major pathway in the liver 
in which it is oxidized into betaine[42-44].
Contributions to the tCho peak
The contribution of  the nine methyl protons of  free 
choline, which resonate at 3.19 ppm, to the tCho peak 
is limited as the concentration of  free choline is usually 
low. Another potential contribution to the tCho peak 
may come from PtdCho, which makes up a very high 
proportion of  the cell plasma membrane. However, it is 
a large molecule with a relatively short T2 relaxation time 
that becomes even shorter by being incorporated into 
a membrane. Therefore, it is almost invisible in the in 
vivo 1H MR spectrum. Nevertheless, some evidence sug-
gests that PtdCho may contribute to the tCho signal[45]. 
Precursors of  PtdCho such as PCho and phosphoryle-
thanolamine (PEtn) are more likely to contribute to 1H 
MR spectra as these are small molecules with long T2 
relaxation times. Experimental evidence suggests that 
the tissue levels of  PCho and PEtn increase during cell 
proliferation and tCho levels also have been correlated 
with tumor aggressiveness[46]. In addition to PCho and 
PEtn [together called phosphomonoesters (PME)] their 
glycerol derivatives glycerol-3-phosphorylcholine (GP-
Cho) and glycerol-3-phosphorylethanolamine (GPEtn) 
[together called phosphodiesters (PDE)] also contrib-
ute to the tCho signal. Besides protons of  choline and 
ethanolamine containing compounds, protons from 
other metabolites might also resonate around 3.2 ppm, 
e.g., glucose at 3.23 ppm, myo-inositol at 3.27 ppm, and 
taurine at 3.25 ppm. In liver and kidney the resonance at 
about 3.26 ppm is almost entirely composed of  proton 
signals of  betaine (trimethylglycine)[6]. 
Liver tumors and metastases
In vitro  high field 1H MR spectra of  the liver: Soper 
et al[47] performed a diagnostic correlation between MR 
spectra and histopathology. They analyzed liver tissue 
specimens from 54 patients undergoing partial or total 
hepatectomy. The samples included 31 normal, 59 cir-
rhotic and 32 hepatocellular carcinoma (HCC) histologi-
cally confirmed tissues and were analyzed by 1H MRS 
at 8.5 Tesla. They found reduced amounts of  lipids 
and carbohydrate residues and increased tCho in HCC 
compared to all normal and all cirrhotic liver tissue. Cir-
rhotic liver tissue and HCC were distinguished with a 
sensitivity and specificity of  95.8% and 88.9%, respec-
tively. Lactate signals of  variable intensity were found at 
1.3 ppm, probably resulting from anaerobic metabolism 
after excision.
In vivo  liver 1H MR spectrum: In vivo 1H MRS is charac-
terized by a much poorer spectral resolution and SNR than 
in vitro 1H MRS (see above, technical issues). Kuo et al[48] in-
vestigated the value of  in vivo 1H MRS in the assessment 
of  large focal hepatic lesions. They included 43 consecu-
tive patients and 8 normal volunteers in a prospective 
MRS study. MRS was performed at 3.0T with shallow 
and regular breathing. Single voxel PRESS with TE = 
30 ms, TR = 1500 ms, 256 averages, was used to select 
a volume of  2 cm × 2 cm × 3 cm. The voxel of  inter-
est was located in the largest solid portion of  hepatic 
tumors in patients. Healthy liver data was collected from 
an area at the centre of  the right hepatic lobe for normal 
volunteers, or in an uninvolved area of  the right hepatic 
lobe in patients. Patients with diffuse-type HCC, with 
focal nodular hyperplasia and obvious fatty infiltration, 
and histological unconfirmed lesions were excluded. 
Thirty-three lesions (21 HCC, 2 angiosarcomas, 1 lym-
phoma and 9 hemangiomas) were included. They found 
that malignant tumors had elevated tCho resonances 
compared to uninvolved liver or benign tumors, but 
the difference in mean tCho/lipid ratio between malig-
nant tumors or uninvolved liver did not reach statistical 
significance. Several factors may have contributed to 
these results. First of  all, the tumors in this study may 
have contained significant necrotic areas with less viable 
cells. This may have diluted more prominent changes 
observed in areas of  rapid cell turnover, within viable 
tumor tissue and may have caused low signal to noise for 
metabolite signals leading to larger errors. Physiological 
motion due to breathing and cardiac movement will have 
contributed, especially if  the tumor was located in the 
left lobe or at the extreme end of  the right hepatic lobe. 
Finally, three different tumor types were included in the 
malignant group, which may have resulted in a variation 
of  different metabolites in phospholipid metabolism, 
and thus in a more variable tCho resonance. Thus, in vivo 
1H MRS is technically feasible at 3.0T for the evaluation 
of  focal hepatic lesions, but the clinical application of  
the measurement protocol used by Kuo et al[48] is limited 
as normal liver, benign and malignant tumors cannot be 
clearly differentiated.
In the second part of  their study Kuo et al[48] attempt-
ed to measure metabolic changes in HCC after trans-
catheter arterial chemoembolization (TACE). Eight HCC 
were evaluated before and two to five days after TACE. 
The tCho peak at 3.2 ppm was significantly decreased 
while the lipid and water signals at 1.3 and 4.7 ppm re-
spectively, were increased. The mean tCho/lipid ratio 
significantly decreased from 0.23 ± 0.11 before to 0.01 
± 0.00 after TACE treatment. One of  the post-TACE 
lesions showed recurrence three months later and MRS 
also revealed an elevated tCho/lipid ratio at that stage. 
Therefore, 1H MRS at 3.0T may be used for treatment 
monitoring.
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Fishbach et al[49] improved the MRS acquisition and 
processing protocol compared to previous studies by in-
troducing a control of  respiratory motion using breath-
hold acquisitions and an abdominal compression belt. 
They also applied dedicated pre- and post-processing 
including automatic phase and frequency correction 
based on the residual and the unsuppressed water signal 
in order to remove potential distortions mainly intro-
duced by motion. Apart from 39 volunteers, they in-
cluded 55 patients with advanced cancer with lesions of  
more than 3 cm in diameter in their study (22 metastases 
of  colorectal cancer, 11 hepatocellular carcinomas, 9 
metastases of  breast cancer, 3 metastases of  pancreatic 
cancer and 1 metastasis of  prostate cancer). Liver spec-
tra were acquired at 3.0T using a body transmit/receive 
coil. Breath-hold at end-expiration spectra were acquired 
with the single voxel (2 cm × 2 cm × 2 cm) PRESS tech-
nique with TE=35 ms, TR=2000 ms, 128 averages and 
16 additional unsuppressed water reference lines. The 
intra-individual reproducibility of  this 1H MRS acquisi-
tion in the liver was tested in 25 patients and volunteers 
and judged to be satisfactory. In total 186 spectra were 
acquired and 27 spectra had to be discarded because 
they did not meet the predefined quality specifications. 
The remaining 113 spectra were measured in normal-
appearing parenchyma of  37 patients and 39 volunteers. 
Although, remarkably, tCho signals relative to those 
of  water seemed to be lower in metastatic lesions com-
pared to normal liver tissue, no significant differences 
were observed between malignant liver tumors and 
normal liver parenchyma for any of  the parameters 
analyzed, in particular tCho signals relative to water and 
lipid signals. This was attributed to the large variability 
of  normal values.
The divergent results observed in the above men-
tioned studies might also be due to the multiple contribu-
tions from the unresolved tCho signal. In normal liver 
tissue low concentrations of  PMEs and high concentra-
tions of  PDEs have been shown while in tumor tissue 
elevated levels of  PMEs and decreased levels of  PDEs 
have been observed[50]. This implies that in tumor tis-
sue increased levels of  PMEs may be canceled out by 
decreased PDEs, resulting in an unchanged overall tCho 
level. Different tumor types might also have divergent 
contributions to the unresolved tCho signal. In addition, 
alterations of  the metabolite concentrations might not 
be due to malignancy, but due to proliferating healthy tis-
sue such as a regenerating liver, benign tumors, and even 
some degenerative pathologies. With 31P MRS PME and 
PDE signals can be studied separately as discussed below.
31P MR SPECTROSCOPY
After 1H MRS, phosphorus-31 MR spectroscopy is the 
most commonly used MRS technique to study tumors 
in vivo. Phosphorus has an MR sensitivity of  6.6% com-
pared to proton. However, the chemical shift dispersion 
of  its signals observed in vivo is larger (about 30 ppm vs 
about 10 ppm), resulting in a better spectral resolution. 
Also, 31P MRS is capable of  detecting some key metabo-
lites in tissue energy metabolism such as ATP, PCr, and 
inorganic phosphate (Pi). In addition some important 
metabolites involved in membrane metabolism such as 
PCho and PEtn (together called PME) and their glycerol 
derivatives GPCho and GPE (together called PDE) may 
be resolved. In this respect 31P spectra (Figure 9) are 
more informative than 1H MR spectra in which signals 
of  all choline compounds (tCho) usually are observed 
unresolved at about 3.2 ppm. Furthermore, from 31P MR 
spectra physiological parameters like intracellular pH can 
be deduced from the chemical shift of  the Pi resonance. 
The phosphoryl resonances from large and membrane 
bound compounds may only show up in a phospho-
rous-31 MR spectrum as broad underlying baseline sig-
nals due to their very short T2 values[51].
Unfortunately, due to a lower sensitivity and less fa-
vorable spin relaxation the spatial resolution of  31P MR 
spectra is an order of  magnitude less than that of  1H 
MRS. Higher magnetic fields provide improved experi-
mental conditions for 31P MRS. 
Metabolites visible in 31P MR spectra of liver tumors
Phosphocreatine: The largest peak in 31P MR spectra of  
muscle, brain and other tissues originates from PCr. Its 
spectral position is used as an internal chemical shift ref-
erence and commonly has been assigned a chemical shift 
of  0.00 ppm. PCr is, however, not detectable in spectra 
of  healthy liver since hepatocytes do not express creatine 
kinase under normal circumstances[30]. Tumors, however, 
might express creatine kinase and show some PCr.
Adenosine triphosphate: ATP is the main direct energy 
supply within cells. ATP consists of  adenosine and three 
phosphate groups. The phosphoryl groups, starting with 
those closest to the adenosine moiety, are referred to as α, β, 
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Figure 9  In vivo 31P magnetic resonance spectra of human liver tissue 
obtained from a healthy volunteer (top) and from a patient with hepatocel-
lular carcinoma (bottom). PME: Phosphomonoesters; PDE: Phosphodiesters; 
Pi: Inorganic phosphate; ATP: Adenosine triphosphate. (Reproduced with per-
mission of John Wiley and Sons, www.interscience.wiley.com, from64.)
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and γ phosphates. ATP is produced by ATP synthase from 
inorganic phosphate and adenosine diphosphate (ADP) 
or adenosine monophosphate (AMP). Multiple processes 
in the cell can split ATP into ADP or AMP and inorganic 
phosphate, and use the energy that is released. At a pH of  
7.2, with full magnesium complexation, the resonances of  
ATP appear at -7.52 ppm (α), -16.26 ppm (β), and -2.48 
ppm (γ). The ATP resonances may overlap with the signals 
of  other nucleotides: uridine triphosphate (UTP), guano-
sine triphosphate (GTP) and cytidine triphosphate (CTP). 
Therefore these resonances are sometimes referred to as 
nucleoside triphosphate (NTP), although the others usually 
occur at much lower concentrations.
Inorganic phosphate: Like the level of  ATP that of  
inorganic phosphate (Pi) reflects the cellular phosphory-
lation potential. The chemical shift of  Pi and some other 
phosphorus containing compounds is dependent on the 
intracellular pH (pHi) and magnesium concentrations[52]. 
The protonation or complexation with magnesium of  
phosphate affects the chemical environment of  the 31P 
nucleus and hence its chemical shift. As proton exchange 
is fast on the NMR timescale, the resonance frequency 
is indicative of  the relative amount of  protonated and 
unprotonated molecules, and hence the pH can be de-
duced. The shift in resonance of  Pi relative to PCr is 
most commonly used as it has a large dependence in the 
physiological pH range whereas the chemical shift of  PCr 
is constant in this range. At a pH of  7.2 and normal mag-
nesium level it occurs at 5.02 ppm. The accuracy of  pH 
determination from the Pi-PCr shift is typically 0.05 pH 
units[6]. However, as PCr is not detectable in the normal 
liver the α-ATP resonance is used instead as a reference.
Tumor pH: Due to the Warburg effect and/or hypoxic 
conditions tumor cells preferentially convert glucose to 
lactic acid. Lactic acid is largely dissociated in vivo to H+ 
and lactate-. Normal, as well as tumor cells, have multiple 
systems to continuously export H+ ions to maintain a 
constant pHi, as well as a system for exporting lactic acid 
(but not lactate). This results in a neutral, or a slightly 
alkaline pHi of  intact (tumor) cells. However, since tu-
mors may be poorly vascularized the extracellular tumor 
pH (pHe) of  tumors is more commonly acidic[53-59].
Phosphodiesters: Signals of  PDE occur around 3 ppm 
in 31P MR spectra. Tumor tissue sometimes contains 
significantly lower concentrations of  PDE than healthy 
liver tissue. Some in vitro studies show that the PDE 
levels increase with decreasing growth fraction of  the 
tumor. This suggest that PDE signals may be domi-
nated by breakdown products of  phospholipids[60], and 
the concentration may be an indicator of  the necrotic 
fraction in tumors associated with phospholipid catabo-
lism[61]. The phospholipid derivatives, particularly GP-
Cho and GPEtn, were found to contribute to the PDE 
resonance[61]. Their phosphor spins resonate at 2.76 ppm 
and 3.20 ppm respectively. 
Phosphomonoesters: Resonances of  PME occur at 
about 6 ppm in 31P MR spectra. Increased levels of  PME 
have been hypothesized to be associated with intensified 
cell membrane synthesis, cellular growth, cell nutritional 
state and rate of  cell replication. Several studies identi-
fied increased PME signals as a possible diagnostic 
marker for tumors. PME/PDE ratios were suggested to 
represent altered relative rates of  membrane synthesis, 
catabolism and metabolic turnover[36,60,61]. Phospholipid 
derivatives, particularly PCho and PEtn, contribute to the 
PME resonance[61]. PCho and PEtn resonate at 5.88 ppm 
and 6.78 ppm respectively.
Liver tumors and metastases
In vitro  high field 31P MR spectroscopy of  liver: 
Many in vitro 31P MRS animal studies and several in vitro 
31P MRS studies on human hepatic tumor tissues have 
been performed. Obtaining a fully representative human 
hepatic tissue sample for 31P MRS is difficult as the sur-
gical removal and extraction usually results in a period 
of  ischemia/hypoxia, which affects metabolic processes 
resulting in decreased ATP and increased Pi levels. Nev-
ertheless, in vitro 31P MRS may be used to study signals 
in the PME and PDE peaks that are still unresolved in 
in vivo 31P MR spectra, as these are less affected by short 
periods of  hypoxia.
Bell et al[50] investigated the metabolic changes arising 
in hepatic tumors and the possible systemic effects of  
these tumors on the liver as a whole. Ten biopsy speci-
mens were obtained from hepatic tumors (one cystad-
enoma, four hepatocellular carcinomas, four metastatic 
colonic adenocarcinomas and one metastatic squamous 
cell carcinoma from the lungs). Five histologically 
proven normal tissue samples from the same tumor-
bearing hepatic lobe were obtained immediately after 
the blood supply had been clamped and before partial 
hepatectomy. Six control samples were obtained from 
morphologically normal liver tissue from patients with 
histologically proven chronic pancreatitis and known to 
be free of  any hepatic malignancy. Both 31P spectra with 
proton decoupling and 1H MR spectra with partially 
water suppression were acquired using high-resolution 
11.7T systems. Betaine is the most prominent resonance 
in the in vitro rat liver 1H spectrum but no resonance for 
betaine was observed in any of  the human biopsy sam-
ples, suggesting that its presence is species related. The 
in vitro 31P MRS spectrum showed that over 10 different 
compounds contributed to the PME resonance. The 
five principal resonances were: PCho, PEtn, glucose-
6-phosphate, AMP, and glycerol-3-phosphate. The PDE 
region included at least 3 different compounds. The two 
main components were: GPCho and GPEtn. Compared 
to control tissue, tumor tissue showed significantly lower 
concentrations of  GPCho (0.59 ± 0.15 vs 2.46 ± 0.37) 
and GPEtn (0.57 ± 0.17 vs 2.25 ± 0.46), and elevated 
levels of  PCho (1.36 ± 0.50 vs 0.17 ± 0.11) and PEtn (2.47 
± 0.84 vs 0.16 ± 0.10). It was suggested that the increase 
in PME/NTP observed in in vivo spectra of  HCC and 
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effective. The PME/β-NTP ratio decreased to normal 
values, during either spontaneous or therapy-induced 
regression of  the disease[66]. It was suggested that the 
increased PME (corresponding to PEtn and PCho) was 
due to the need for increased phospholipid synthesis 
in these tissues. This study demonstrated that 31P MRS 
could be used to detect tumors and to monitor their re-
sponse to treatment.
Dixon et al[67,68] studied whether hepatic involvement 
in lymphoma produced biochemical changes that could 
be detected by in vivo 31P MRS of  the liver. Twenty-two 
patients were included. Lymph node biopsies showed 
that eight patients had Hodgkin’s disease and 14 non-
Hodgkin’s lymphoma. Eleven patients of  these 14 had 
high grade lymphoma and three low grade disease. Six 
patients, diagnosed with lymphomatous infiltration of  
the liver on the basis of  liver function tests and either 
ultrasound or CT imaging, had a significantly higher 
PME/Pi ratio (1.43 ± 0.37) or PME/ATP ratio (0.94 ± 
0.27) compared to 25 controls (ages 20-50 years) (0.58 
± 0.11 and 0.37 ± 0.10, respectively) with normal livers. 
The PME/Pi ratio decreased following chemotherapy to 
an average of  66% of  the initial value (range 40%-82%). 
In two patients the ratio fell to the normal range and 
these patients showed clinical remission. Four patients 
whose liver spectra showed persistently high ratios after 
therapy died subsequently of  progressive disease. In vitro 
31P MRS studies of  extracts of  lymphomatous lymph 
nodes suggested that PEtn was largely responsible for 
the increased PME signal. In this study, however, no 
difference was observed between Hodgkin’s and non-
Hodgkin’s lymphoma and between histological grades.
Meyerhoff  et al[69] used 31P MRS to assess the meta-
bolic state of  hepatic cancers and their metabolic re-
sponse to chemoembolization. Their preliminary report 
described studies on five patients (two with colon cancer 
metastasis, two with HCC, and one with adenocarcinoma 
of  unknown primary) and thirteen healthy volunteers. 
Untreated hepatic tumors showed elevated PME/ATP 
ratios, reduced ATP and Pi content, and normal PDE 
levels compared to normal controls. ATP, PME, and/or 
PDE levels diminished as an acute response to chemo-
embolization, whereas Pi content increased or stayed 
relatively constant. This could point to tumor regression 
and/or necrosis. Long-term follow-up after treatment 
showed decreased PME/ATP and increased ATP levels, 
even in the absence of  changes on standard imaging. 
This could be the result of  returning normal liver tissue 
and thus recovery.
Negendank[70] reviewed hundreds of  cancer cases 
in 31P and/or 1H MRS studies that were published up 
to early 1992. In general he found that human cancers, 
other than brain, of  different types in different loca-
tions had similar metabolic characteristics: 173 of  194 
cases had high PME and levels, 121 of  166 cases had 
high PDE levels, 59 of  125 cases had high Pi levels and 
96 of  117 cases had low PCr. Table 1 lists the cases 
with HCC, metastatic liver cancer and lymphoma in the 
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liver metastasis (see next section) is due to increased lev-
els of  PCho and PEtn. The decrease in concentration in 
GPC and GPE observed in this study might be respon-
sible for the change in PDE/NTP seen in in vivo spectra. 
However, the underlying cause of  these changes remains 
partially unknown and requires further study.
Bell et al[50] also observed that spectra from histologi-
cally normal tissue from the liver tumor-bearing hepatic 
lobe contained more PCho (0.32 ± 0.18 vs 0.17 ± 0.06) 
and PEtn (0.34 ± 0.12 vs 0.16 ± 0.07) than spectra ob-
tained from control tissue. The levels of  GPC and GPE 
showed no significant change.
Previously, in 1993 Dagnelie et al[62] studied liver 
metabolic changes in rats bearing subcutaneous Dun-
ning prostate tumors by in vivo and in vitro 31P MRS. Al-
though absence of  metastatic tumor cells in the liver of  
all tumor-bearing animals was confirmed by histological 
examination, hepatic phosphorylation status, phospho-
lipid metabolism, and gluconeogenesis was significantly 
affected in the tumor-bearing animals. Dagnelie et al[63] 
also investigated liver metabolism in humans with meta-
static cancer without evidence of  liver metastases by 31P 
in vivo MRS. They included 23 cancer patients and 12 
healthy subjects and found markedly elevated PME and 
reduced PDE levels in the non-metastatic liver com-
pared to controls. 
Thus this may complicate the use of  increased PME 
(PCho and PEtn) levels as a sole diagnostic biomarker to 
detect (metastatic) liver cancer. In addition, as no signifi-
cant differences between HCC and liver metastasis were 
observed in biopsy samples by in vitro 31P MRS[50,64], the 
use of  in vivo 31P MRS seems limited in this differentiation.
In vivo  31P MRS of  the liver: In 1985 Maris et al[65] 
combined the results of  in vivo and in vitro 31P MR spec-
troscopy studies to compare the spectral characteristics 
of  the liver of  2 children, one infant with neuroblastoma 
stage Ⅳ-S and the other with neuroblastoma stage Ⅳ 
disease. The 31P MR spectra from the primary tumor in 
the latter infant, and the spectra from the infiltrated liver 
regions in both the infants showed substantially elevated 
PME/β-NTP ratios compared with a spectrum from a 
normal control. The ratio increased during periods of  
rapid progression and persisted until treatment became 
High PME High PDE High Pi Low PCr
  HCC   91% 
  (of 11 cases)
75% 
(of 4 cases)
    0% 
(of 4 cases)
100% 
  (of 11 cases)
  Liver metastasis 100% 
(of 7 cases)
33% 
(of 6 cases)
  17% 
(of 6 cases)
100% 
(of 4 cases)
  Liver lymphoma 100% 
(of 6 cases)
17% 
(of 6 cases)
100% 
(of 6 cases)
100% 
(of 6 cases)
Table 1  Number of different cases  
“High” and “low” levels are relative to the amount in normal or benign 
tissue (from Negendank[70]). PME: Phosphomonoesters; PDE: Phosphodi-
esters; Pi: Inorganic phosphate; PCr: Phosphorylated creatine; HCC: Hepa-
tocellular carcinoma. 
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dispersion of  13C MRS in vivo is large (about 200 ppm) 
and is also characterized by narrow line widths, resulting 
in a very good spectral resolution (Figure 10). Although 
13C MR spectroscopy is primarily known for MRS of  
13C-labeled substrates (e.g., glucose), natural abundance 
13C MRS can also be applied.
Metabolites visible in natural abundance 13C MR spectra 
Almost all metabolites in the human body contain car-
bon and therefore in principle a large amount of  me-
tabolites can be investigated with 13C MRS, but because 
of  the 1.11% natural abundance this is restricted to only 
a few highly concentrated compounds such as lipids. 
Chemical shifts above 150 ppm are indicative of  carbonyl 
groups; carbons adjacent to hydroxyl groups typically 
resonate in the 60-100 ppm range; CH, CH2, CH3 groups 
resonate in the 45-60 ppm, 25-45 ppm and < 25 ppm 
ranges, respectively. The resonances of  -CH = CH- 
groups are located around 125 ppm. Dominant lipid 
resonances are usually found in non-brain tissue. Two 
distinct resonances at 63 and 73 ppm originate from the 
glycerol backbone[6].
13C labled metabolites visible in 13C MR spectra
13C MRS with labeled substrates is the only way to 
study metabolic conversions in the living intact body. 
Substrates enriched with 13C are usually administrated 
intravenously to reach a high and stable level in the 
blood. One of  the most commonly used enriched sub-
strate in humans is [1-13C]glucose. Other known sub-
strates are [1,2-13C2]-choline, [1,2-13C2]-ethanolamine, 
[3-13C]pyruvate and lactate, [2-13C]acetate, [2-13C]glucose 
and [1,6-13C2]glucose. The latter, often used in studies 
involving rats and mice, results in two labeled [3-13C]-
pyruvate molecules, and thus more signal. Pyruvate is 
an intermediate common to three major metabolic and 
catabolic pathways. After i.v. injection, pyruvate is rapidly 
distributed in the body and taken up by most cells, and 
then converted into alanine, lactate, or carbon dioxide, 
depending on the intracellular energy status.
Liver tumors and metastases
Natural abundance 13C MR liver spectrum: In 1983 
Bottomley et al[71] demonstrated the feasibility of  natu-
ral abundance 13C MRS at 1.5T. The low sensitivity and 
the fact that most information could also be obtained 
from 1H and 31P MRS spectra has prevented widespread 
application of  natural abundance 13C MRS. However, 
there are areas where it has some advantages such as in 
the detection of  glycogen. Carbohydrate reserves are 
mainly stored as glycogen in animals and humans, in 
particular in muscle and liver. Natural abundance 13C 
MRS detection of  glycogen is typically performed via the 
glycogen-C1 resonance at 100.5 ppm[72]. Some studies on 
rats have indicated that glycogen levels in hepatic tumors 
were markedly less than those observed in livers of  con-
trol animals[73,74]. 
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liver. The most frequently used characteristic that dif-
ferentiated healthy liver tissue from liver lymphoma was 
an increased PME level, and an increased PME/Pi and 
increased PME/Pi for HCC, and increased PME/NTP 
and increased PDE/NTP ratios for metastasis in the liv-
er. Also, an early decrease in PME (or in the PME/PDE 
ratio) was a good predictor of  response to whatever 
treatment.
Concluding remarks
From these studies it appears that the increase of  PME 
levels is associated with tumor progression and that suc-
cessful treatment is associated with its decrease. There-
fore 31P MRS seems very suitable for treatment response 
monitoring. Since 2003, however, only a limited number 
of  in vivo 31P MRS studies on liver tumors and metastasis 
have been reported. The reason for this could be the low 
spatial and time resolution of  in vivo 31P MRS on 1.5T 
MR systems. Currently, 3T MR systems have become 
widely available, dual tuned multi-channel 31P/1H coils 
have been developed and several techniques, e.g., 1H de-
coupling, nuclear overhauser enhancement, polarization 
transfer, have been demonstrated[16] to improve 31P MRS 
sensitivity and spectral resolution. Finally, high field in 
vitro 31P MRS of  cell cultures might establish new mark-
ers to distinguish different tumor types and to separate 
benign from malignant tumors.
13C MR SPECTROSCOPY
As carbon-12 has no net nuclear spin it cannot be de-
tected by MR spectroscopy. In contrast, 13C can be de-
tected by MRS but it has a natural abundance of  only 
1.11%. Therefore 13C has a relatively low MR sensitivity. 
In addition, the signal to noise ratio may be negatively 
affected by 1H coupling. To obtain spectra with accept-
able signal to noise it is needed to apply averaging, polar-
ization transfer, and 1H decoupling. The chemical shift 
Glycogen
175              150               125               100               75                50
                          Frequency (ppm)
Figure 10  In vivo 13C magnetic resonance spectra (1.5T) of human liver 
tissue obtained from a healthy volunteer before (bottom) and after exer-
cise (top). Resonances of glycogen (101 ppm and around 75 ppm) are reduced 
after exercise. Other resonances are mainly lipids.
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13C labled 13C MR liver spectrum
13C-labeled glucose: Infusion of  enriched 13C-labeled 
glucose in combination with 13C MRS can provide highly 
specific information on metabolites and metabolic rates 
involved in energy metabolism. The 13C-labeled glucose is 
transported into the cell in the same way as 18FDG used 
in PET[75]. Where the derivative of  18FDG is trapped 
inside the cell, indicating areas of  high glucose transport 
and thus indirectly indicating glycolytic activity, the 13C-
labeled glucose will enter metabolic pathways like gly-
colysis and the TCA cycle. This allows the direct study of  
glucose uptake, the flux through labeled metabolites, rela-
tive contributions of  glycolytic pathways and oxidative 
phosphorylation, as well as oxygen consumption[12,76].
13C labeled glucose combined with 13C MRS in hu-
man liver tissue is, however, not without difficulties and 
the number of  studies with this technique is still very 
limited. In 2008 Tomiyasu et al[77] monitored liver gly-
cogen synthesis in diabetic patients using 13C MRS on a 
3.0T system. The MR signals of  liver [1-13C]-glucose and 
glycogen were assessed and a correlation between the 
quantity of  liver glycogen and the fasting plasma glucose 
levels was found. To investigate glucose metabolism of  
liver tumors would be of  great interest, but such studies 
are still lacking.
13C-labeled ethanolamine and choline in experimen-
tal tumors: Dixon et al[67,78] administrated [13C2]-etha-
nolamine to mice with lymphomatous liver to study the 
kinetics of  PtdEtn synthesis[79]. The newly synthesized 
PEtn and PtdEtn could be distinguished from naturally-
abundant compounds by their 13C label. The results 
showed that PtdEtn synthesis in the normal liver largely 
follows the Kennedy pathway. The data extracted from 
the 13C MR spectra were fitted to a kinetic model repre-
senting this pathway, which allowed them to determine 
the approximate rates of  the various enzymes in the syn-
thetic pathway in vivo. They also showed that the overall 
rate of  PtdEtn synthesis from Etn was not increased in 
lymphomatous liver. 
Katz-Brull et al[35] investigated the distribution of  me-
tabolites following infusion of  [1,2-13C]-choline by 13C 
MRS in mice. In their study MCF7 human breast can-
cer cells were inoculated s.c. in the right flank of  CD-1 
female athymic mice. In the tumors significantly more 
PCho (labeled and unlabeled) was observed than in 
normal liver and kidney tissue. Therefore, 13C MRS com-
bined with modeling can be used to study choline and 
ethanolamine metabolism and enzymes rates in mice.
Hyperpolarization and tumor metabolism: Gallagher 
et al[80] performed a 13C MRS in vitro study of  glutaminase 
activity in human hepatocellular carcinoma cells using 
DNP hyperpolarized 13C-labeled glutamine. They showed 
that the conversion of  hyperpolarized [5-13C]glutamine 
to glutamate senses intramitochondrial glutaminase ac-
tivity in hepatoma cells. These results represented the 
first step in the development of  an imaging technique 
for the detection of  glutamine metabolism in vivo. The 
rate of  glutamine uptake and metabolism to glutamate in 
HCC cells was shown to be up to 30-fold higher than in 
normal hepatocytes. And thus this approach has clinical 
potential such as in the detection of  small HCC in the 
presence of  a cirrhotic liver. This study also suggests a 
new technique to detect changes in tumor cell prolifera-
tion in response to cytotoxic treatment since glutamine 
utilization has been correlated with cell proliferation. 
Golman et al[75] conducted a metabolic imaging study 
in P22 tumors implanted on the back of  rats. The high 
signal, due to DNP hyperpolarization, allowed mapping 
of  pyruvate, lactate and alanine in a 5 mm × 5 mm × 
10 mm imaging voxel using a 1.5T scanner. Tumor tis-
sue showed a significantly higher lactate content than 
normal tissue, possibly explained by the Warburg effect. 
The results indicate that fast noninvasive quantification 
may be possible. To show that the DNP technique can 
be used both in small and larger animals, Golman et al[81] 
also conducted nearly similar real-time metabolic imag-
ing studies in rats and pigs. The pig study would provide 
important information as to whether [1-13C] enriched hy-
perpolarized dynamics also could be visualized in a more 
clinically relevant setting. They showed that in both spe-
cies, where pharmacokinetic parameters widely differ, it 
is possible to map pyruvate and some of  its metabolites 
in resting skeletal muscle within a clinically useful time 
frame of  about 10 seconds. This indicates the technique 
may work in humans as well.
Concluding remarks
Hyperpolarization is a promising technique in MR can-
cer research. Similar images as those in 18FDG-PET 
can be obtained, but with the further advantages that, 
without radiation, real (glucose) metabolism is observed. 
Although this new MR method is far more sensitive than 
conventional 13C MRS it only allows measurement of  
single step metabolic conversions associated with rapid 
cellular uptake of  the administered substrate. Therefore, 
conventional 13C MRS studies will remain valuable to 
understand and complement results from hyperpolarized 
13C MR imaging.
CONCLUSION
Hydrogen is the most commonly studied nucleus, as it 
has the highest sensitivity compared to 31P and 13C, and 
essentially can be performed with the same hardware as 
for standard MR imaging. In liver tumor studies the lac-
tate resonance is related to energy metabolism (Warburg 
effect) of  the tumor. Proton resonances of  mobile lipids 
and the peak of  total choline (tCho) have been explored 
as biomarkers to identify malignant tumors. However, 
the tCho peak is composed of  several unresolved reso-
nances of  different choline containing compounds, 
which makes changes in this signal difficult to interpret. 
With 31P MRS phosphorylated choline and ethanol-
amine containing compounds can be resolved. From 
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several studies it is known that the increase of  PME is 
associated with tumor progression and that successful 
treatment is associated with a decrease of  PME levels. 
Therefore 31P MRS could very well be used for treatment 
response monitoring. Besides the signals from phos-
pholipid metabolism, 31P MR spectra of  liver also show 
signals of  ATP and Pi which can be used to investigate 
tumor energy metabolism.
MRS with 13C as label is a unique method to measure 
the dynamics of  metabolic conversions in vivo, but it has 
hardly been used to examine human liver metabolism 
due to its technical complexity and relatively low sensi-
tivity. However, developments such as hyperpolarization 
may open new ways of  liver assessment and imaging. 
In vivo MR spectroscopy provides a number of  ade-
quate research tools to study metabolism in liver tumors 
and metastasis. However, they are not yet applied often 
in a clinical setting for diagnosis and treatment monitor-
ing. This may be due to technical challenges associated 
with the body location of  the liver, relatively long scan 
times needed for a good signal to noise ratio, the need 
for additional hardware (except 1H MRS) and the need 
for expertise in spectral interpretation. With higher mag-
net fields becoming available, new multi-element detec-
tion probes, new acquisition techniques for improved 
spatial and time resolution, better postprocessing, and 
with new biomarkers it is expected that the research and 
clinical usefulness of  MRS of  liver and tumors therein 
will increase. 
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